Skip to content

Exploring Radiotherapy of Temporomandibular Joint Arthritis

Exploring Radiotherapy of Temporomandibular Joint Arthritis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05716737
Enrollment
10
Registered
2023-02-08
Start date
2023-07-07
Completion date
2027-07-07
Last updated
2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis of Temporomandibular Joint

Brief summary

With this pilot study, the acute side effects and potential pain relieve after radiotherapy (RT) of the temporomandibular joint (TMJ) are prospectively recorded. For this purpose, the symptoms of the jaw joint arthrosis/arthritis are recorded using a symptom-oriented questionnaire and the numeric rating scale for pain assessment. Furthermore, it is examined whether the irradiation is feasible.

Interventions

RADIATIONIrradiation

3 Gy in 6 fractions to the TMJ, every other day, LINAC based

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* TMJ arthritis * diagnosed by a surgeon for oral and maxillofacial surgery or a dentist

Exclusion criteria

* Previous irradiation in the TMJ area * Age below 50 years

Design outcomes

Primary

MeasureTime frameDescription
therapeutic effectBefore, directly after treatment and after 3, 6 9 and 12 monthsPain, Numeric rating scale (0-10, 0=no pain, 10=maximum pain)

Secondary

MeasureTime frameDescription
Other temporomandibular joint conditionsBefore, directly after treatment and after 3, 6 9 and 12 monthsQuestionnaire (covering the condition of the temporomandibular joint and masticatory muscles, Version: 12.03.2018 (FB II) of the University of Leipzig)

Countries

Austria

Contacts

Primary ContactCora Waldstein, MD
Cora.waldstein@meduniwien.ac.at004314040026920
Backup ContactMatthias Moll, MD
matthias.moll@meduniwien.ac.at004314040026920

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026